Acessibilidade / Reportar erro

Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports

Botox® após Botox® - uma nova abordagem para tratamento de diplopia secundária ao uso cosmético de toxina botulínica: relatos de casos

A new technique for the treatment of diplopia secondary to cosmetic botulinum toxin A use is described. In this interventional case reports, two consecutive patients who developed diplopia after periocular cosmetic use of botulinum toxin A were treated with intramuscular botulinum toxin A injection into the antagonist extraocular muscle. Diplopia resolved in both patients in less than 1 week with no side effects or complications. In conclusion, the injection of intramuscular botulinum toxin A is an encouraging option for treatment of diplopia secondary to botulinum toxin A use for facial lifting.

Botulinum toxins, type A; Strabismus; Diplopia; Neuromuscular agents; Humans; Female; Adult; Case reports


Conselho Brasileiro de Oftalmologia Rua Casa do Ator, 1117 - cj.21, 04546-004 São Paulo SP Brazil, Tel: 55 11 - 3266-4000, Fax: 55 11- 3171-0953 - São Paulo - SP - Brazil
E-mail: abo@cbo.com.br